| __timestamp | Alpine Immune Sciences, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 22570000 |
| Thursday, January 1, 2015 | 6844000 | 24378000 |
| Friday, January 1, 2016 | 8586000 | 26621000 |
| Sunday, January 1, 2017 | 6079000 | 28653000 |
| Monday, January 1, 2018 | 8362000 | 37734000 |
| Tuesday, January 1, 2019 | 9467000 | 41884000 |
| Wednesday, January 1, 2020 | 10899000 | 64435000 |
| Friday, January 1, 2021 | 14560000 | 57483000 |
| Saturday, January 1, 2022 | 17968000 | 70062000 |
| Sunday, January 1, 2023 | 22222000 | 52790000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Alpine Immune Sciences, Inc. and Ligand Pharmaceuticals Incorporated, two prominent players, have shown contrasting strategies over the past decade. From 2014 to 2023, Alpine Immune Sciences saw a nearly tenfold increase in SG&A expenses, peaking at $22 million in 2023. This reflects a strategic investment in growth and expansion. In contrast, Ligand Pharmaceuticals maintained a more stable trajectory, with expenses fluctuating between $23 million and $70 million, indicating a focus on consistent operational efficiency. Notably, Ligand's expenses surged by 185% from 2014 to 2022, before a slight dip in 2023. This comparison highlights the diverse approaches companies can take in optimizing costs, balancing between aggressive growth and steady management.
Who Optimizes SG&A Costs Better? Sanofi or Alpine Immune Sciences, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Novavax, Inc.
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or Ligand Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Merus N.V. vs Ligand Pharmaceuticals Incorporated